Skip to content

Dr Reddy’s Q3 Preview | Sharp drop in net profit likely on slump in US revenues

Revlimid sale contribution to US revenue likely to fall as it normalises, making for a muted December Quarter

Read More

​ Revlimid sale contribution to US revenue likely to fall as it normalises, making for a muted December Quarter Revlimid sale contribution to US revenue likely to fall as it normalises, making for a muted December Quarter  Moneycontrol Latest News Read More  

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish